JMJD3 deficiency disturbs dopamine biosynthesis in midbrain and aggravates chronic inflammatory pain

Xi-Biao He1, Fang Guo2, Wei Zhang3

  • 1Laboratory of Stem Cell Biology and Epigenetics, School of Basic Medical Sciences, Shanghai University of Medicine & Health Sciences, 279 Zhouzhu Highway, Pudong New Area, Shanghai, 201318, China. hexb@sumhs.edu.cn.

PubMed

Insights

Histone demethylase JMJD3 regulates dopamine (DA) biosynthesis in midbrain dopamine (mDA) neurons. JMJD3 deficiency reduces DA levels and prolongs pain, impacting brain function.

Area of Science:

  • Neuroscience
  • Epigenetics
  • Molecular Biology

Background:

  • Midbrain dopamine (mDA) neurons regulate crucial brain functions via dopamine (DA) biosynthesis.
  • Epigenetic mechanisms controlling DA biosynthesis in mDA neurons remain largely uncharacterized.

Purpose of the Study:

  • To investigate the role of histone demethylase JMJD3 in regulating DA biosynthesis in adult mouse mDA neurons.
  • To elucidate the molecular mechanisms underlying JMJD3's function in mDA neurons.

Main Methods:

  • Conditional knockout of Jmjd3 in adult mice.
  • Pharmacological inhibition of JMJD3.
  • Measurement of DA content in midbrain and striatum.
  • Histological analysis of TH and NURR1 expression.
  • In vivo and in vitro mechanistic studies on gene transcription and epigenetic modifications.
  • Behavioral tests for pain and motor function.

Main Results:

  • Jmjd3 deficiency led to reduced DA content in the midbrain and striatum.
  • Expression of TH and NURR1 was decreased in mDA neurons of knockout mice.
  • JMJD3 deficiency suppressed Th and Nurr1 transcription due to increased H3K27me3 and reduced JMJD3/NURR1 binding at gene promoters.
  • Conditional knockout mice exhibited prolonged inflammation-induced mechanical hyperalgesia, while motor function remained unaffected.

Conclusions:

  • Histone demethylase JMJD3 is a critical regulator of DA biosynthesis in adult mDA neurons.
  • JMJD3 deficiency impairs DA homeostasis and leads to chronic inflammatory pain as a consequence of DA level reduction.